Diffuse	B:C2832047
traumatic	I:C2832047
brain	I:C2832047
injury	I:C2832047
affects	O
chronic	O
corticosterone	O
function	O
in	O
the	O
rat	O
.	O

Diffuse	O
traumatic	I:C2832047
brain	I:C2832047
injury	I:C2832047
affects	O
chronic	O
corticosterone	B:C0010124
function	O
in	O
the	O
rat	O
.	O

Diffuse	O
traumatic	I:C2832047
brain	I:C2832047
injury	I:C2832047
affects	O
chronic	O
corticosterone	O
function	O
in	O
the	O
rat	B:C0034721
.	O

As	O
many	O
as	O
20	O
-	O
55	O
%	O
of	O
patients	O
with	O
a	O
history	B:C0332119
of	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
(	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
)	O
experience	O
chronic	O
endocrine	O
dysfunction	O
,	O
leading	O
to	O
impaired	O
quality	O
of	O
life	O
,	O
impaired	O
rehabilitation	O
efforts	O
and	O
lowered	O
life	I:C1504437
expectancy	I:C1504437
.	O

As	O
many	O
as	O
20	O
-	O
55	O
%	O
of	O
patients	O
with	O
a	O
history	O
of	O
traumatic	B:C0876926
brain	I:C0876926
injury	I:C0876926
(	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
)	O
experience	O
chronic	O
endocrine	O
dysfunction	O
,	O
leading	O
to	O
impaired	O
quality	O
of	O
life	O
,	O
impaired	O
rehabilitation	O
efforts	O
and	O
lowered	O
life	I:C1504437
expectancy	I:C1504437
.	O

As	O
many	O
as	O
20	O
-	O
55	O
%	O
of	O
patients	O
with	O
a	O
history	O
of	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
(	O
traumatic	B:C0876926
brain	I:C0876926
injury	I:C0876926
)	O
experience	O
chronic	O
endocrine	O
dysfunction	O
,	O
leading	O
to	O
impaired	O
quality	O
of	O
life	O
,	O
impaired	O
rehabilitation	O
efforts	O
and	O
lowered	O
life	I:C1504437
expectancy	I:C1504437
.	O

As	O
many	O
as	O
20	O
-	O
55	O
%	O
of	O
patients	O
with	O
a	O
history	O
of	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
(	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
)	O
experience	O
chronic	O
endocrine	O
dysfunction	O
,	O
leading	O
to	O
impaired	O
quality	O
of	O
life	O
,	O
impaired	O
rehabilitation	O
efforts	O
and	O
lowered	B:C1504437
life	I:C1504437
expectancy	I:C1504437
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	B:C0876926
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	O
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	O
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	B:C0006104
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	O
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	O
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	B:C2951888
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	O
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	O
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	B:C0020663
and	O
pituitary	O
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	O
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	B:C0032005
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	O
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	O
neuropathology	B:C1540677
,	O
and	O
subsequent	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	O
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	O
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	B:C0014136
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	O
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	O
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	B:C0014136
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	O
.	O

Endocrine	O
dysfunction	O
after	O
traumatic	O
brain	I:C0876926
injury	I:C0876926
is	O
thought	O
to	O
result	O
from	O
acceleration	O
-	O
deceleration	O
forces	O
to	O
the	O
brain	O
within	O
the	O
skull	O
,	O
creating	O
enduring	O
hypothalamic	O
and	O
pituitary	O
neuropathology	O
,	O
and	O
subsequent	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
(	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
)	O
dysfunction	B:C0277785
.	O

These	O
experiments	B:C0681814
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	O
TBI	I:C2832047
results	O
in	O
chronic	O
dysfunction	O
of	O
corticosterone	O
(	O
corticosterone	O
)	O
,	O
a	O
glucocorticoid	O
released	O
in	O
response	O
to	O
stress	O
and	O
testosterone	O
.	O

These	O
experiments	O
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	B:C2832047
TBI	I:C2832047
results	O
in	O
chronic	O
dysfunction	O
of	O
corticosterone	O
(	O
corticosterone	O
)	O
,	O
a	O
glucocorticoid	O
released	O
in	O
response	O
to	O
stress	O
and	O
testosterone	O
.	O

These	O
experiments	O
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	O
TBI	I:C2832047
results	O
in	O
chronic	O
dysfunction	B:C0277785
of	O
corticosterone	O
(	O
corticosterone	O
)	O
,	O
a	O
glucocorticoid	O
released	O
in	O
response	O
to	O
stress	O
and	O
testosterone	O
.	O

These	O
experiments	O
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	O
TBI	I:C2832047
results	O
in	O
chronic	O
dysfunction	O
of	O
corticosterone	B:C0010124
(	O
corticosterone	O
)	O
,	O
a	O
glucocorticoid	O
released	O
in	O
response	O
to	O
stress	O
and	O
testosterone	O
.	O

These	O
experiments	O
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	O
TBI	I:C2832047
results	O
in	O
chronic	O
dysfunction	O
of	O
corticosterone	O
(	O
corticosterone	B:C0010124
)	O
,	O
a	O
glucocorticoid	O
released	O
in	O
response	O
to	O
stress	O
and	O
testosterone	O
.	O

These	O
experiments	O
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	O
TBI	I:C2832047
results	O
in	O
chronic	O
dysfunction	O
of	O
corticosterone	O
(	O
corticosterone	O
)	O
,	O
a	O
glucocorticoid	B:C0017710
released	O
in	O
response	O
to	O
stress	O
and	O
testosterone	O
.	O

These	O
experiments	O
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	O
TBI	I:C2832047
results	O
in	O
chronic	O
dysfunction	O
of	O
corticosterone	O
(	O
corticosterone	O
)	O
,	O
a	O
glucocorticoid	O
released	O
in	O
response	O
to	O
stress	B:C0449430
and	O
testosterone	O
.	O

These	O
experiments	O
were	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
single	O
diffuse	O
TBI	I:C2832047
results	O
in	O
chronic	O
dysfunction	O
of	O
corticosterone	O
(	O
corticosterone	O
)	O
,	O
a	O
glucocorticoid	O
released	O
in	O
response	O
to	O
stress	O
and	O
testosterone	B:C0039601
.	O

We	O
used	O
a	O
rodent	B:C1519106
model	I:C1519106
of	O
diffuse	O
TBI	I:C2832047
induced	O
by	O
midline	O
fluid	I:C3714660
percussion	I:C3714660
injury	I:C3714660
(	O
midline	O
fluid	I:C3714660
percussion	I:C3714660
injury	I:C3714660
)	O
.	O

We	O
used	O
a	O
rodent	O
model	I:C1519106
of	O
diffuse	B:C2832047
TBI	I:C2832047
induced	O
by	O
midline	O
fluid	I:C3714660
percussion	I:C3714660
injury	I:C3714660
(	O
midline	O
fluid	I:C3714660
percussion	I:C3714660
injury	I:C3714660
)	O
.	O

We	O
used	O
a	O
rodent	O
model	I:C1519106
of	O
diffuse	O
TBI	I:C2832047
induced	O
by	O
midline	B:C3714660
fluid	I:C3714660
percussion	I:C3714660
injury	I:C3714660
(	O
midline	O
fluid	I:C3714660
percussion	I:C3714660
injury	I:C3714660
)	O
.	O

We	O
used	O
a	O
rodent	O
model	I:C1519106
of	O
diffuse	O
TBI	I:C2832047
induced	O
by	O
midline	O
fluid	I:C3714660
percussion	I:C3714660
injury	I:C3714660
(	O
midline	B:C3714660
fluid	I:C3714660
percussion	I:C3714660
injury	I:C3714660
)	O
.	O

At	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	B:C1511501
control	I:C1511501
animals	I:C1511501
,	O
circulating	O
levels	O
of	O
corticosterone	O
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	O
stress	I:C0449430
and	O
in	O
response	O
to	O
dexamethasone	O
,	O
a	O
synthetic	O
glucocorticoid	I:C0017711
commonly	O
used	O
to	O
test	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
axis	O
regulation	O
.	O

At	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	O
control	I:C1511501
animals	I:C1511501
,	O
circulating	O
levels	O
of	O
corticosterone	B:C0010124
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	O
stress	I:C0449430
and	O
in	O
response	O
to	O
dexamethasone	O
,	O
a	O
synthetic	O
glucocorticoid	I:C0017711
commonly	O
used	O
to	O
test	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
axis	O
regulation	O
.	O

At	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	O
control	I:C1511501
animals	I:C1511501
,	O
circulating	O
levels	O
of	O
corticosterone	O
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	B:C0449430
stress	I:C0449430
and	O
in	O
response	O
to	O
dexamethasone	O
,	O
a	O
synthetic	O
glucocorticoid	I:C0017711
commonly	O
used	O
to	O
test	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
axis	O
regulation	O
.	O

At	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	O
control	I:C1511501
animals	I:C1511501
,	O
circulating	O
levels	O
of	O
corticosterone	O
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	O
stress	I:C0449430
and	O
in	O
response	O
to	O
dexamethasone	B:C0011777
,	O
a	O
synthetic	O
glucocorticoid	I:C0017711
commonly	O
used	O
to	O
test	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
axis	O
regulation	O
.	O

At	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	O
control	I:C1511501
animals	I:C1511501
,	O
circulating	O
levels	O
of	O
corticosterone	O
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	O
stress	I:C0449430
and	O
in	O
response	O
to	O
dexamethasone	O
,	O
a	O
synthetic	B:C0017711
glucocorticoid	I:C0017711
commonly	O
used	O
to	O
test	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
axis	O
regulation	O
.	O

At	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	O
control	I:C1511501
animals	I:C1511501
,	O
circulating	O
levels	O
of	O
corticosterone	O
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	O
stress	I:C0449430
and	O
in	O
response	O
to	O
dexamethasone	O
,	O
a	O
synthetic	O
glucocorticoid	I:C0017711
commonly	O
used	O
to	O
test	O
hypothalamic	B:C0014136
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
axis	O
regulation	O
.	O

At	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	O
control	I:C1511501
animals	I:C1511501
,	O
circulating	O
levels	O
of	O
corticosterone	O
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	O
stress	I:C0449430
and	O
in	O
response	O
to	O
dexamethasone	O
,	O
a	O
synthetic	O
glucocorticoid	I:C0017711
commonly	O
used	O
to	O
test	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
axis	B:C1522496
regulation	O
.	O

At	O
2	O
months	O
postinjury	O
compared	O
with	O
uninjured	O
control	I:C1511501
animals	I:C1511501
,	O
circulating	O
levels	O
of	O
corticosterone	O
were	O
evaluated	O
at	O
rest	O
,	O
under	O
restraint	O
stress	I:C0449430
and	O
in	O
response	O
to	O
dexamethasone	O
,	O
a	O
synthetic	O
glucocorticoid	I:C0017711
commonly	O
used	O
to	O
test	O
hypothalamic	O
-	I:C0014136
pituitary	I:C0014136
endocrine	I:C0014136
axis	O
regulation	B:C1327622
.	O

Testosterone	B:C0039601
was	O
evaluated	O
at	O
rest	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	B:C3714660
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	B:C0027882
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	B:C0487602
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	B:C1540677
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	B:C0487602
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	B:C1326120
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	B:C0004112
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	B:C0487602
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	B:C0030532
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	B:C0030532
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	O
.	O

Further	O
,	O
we	O
assessed	O
changes	O
in	O
injury	O
-	O
induced	O
neuron	O
morphology	O
(	O
Golgi	O
stain	I:C0487602
)	O
,	O
neuropathology	O
(	O
silver	O
stain	I:C0487602
)	O
and	O
activated	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
(	O
paraventricular	O
nucleus	I:C0030532
)	O
of	O
the	O
hypothalamus	B:C0020663
.	O

Resting	O
plasma	B:C0032105
corticosterone	O
levels	O
were	O
decreased	O
at	O
2	O
months	O
postinjury	O
and	O
there	O
was	O
a	O
blunted	O
corticosterone	O
increase	O
in	O
response	O
to	O
restraint	O
induced	I:C0449430
stress	I:C0449430
.	O

Resting	O
plasma	O
corticosterone	B:C0010124
levels	O
were	O
decreased	O
at	O
2	O
months	O
postinjury	O
and	O
there	O
was	O
a	O
blunted	O
corticosterone	O
increase	O
in	O
response	O
to	O
restraint	O
induced	I:C0449430
stress	I:C0449430
.	O

Resting	O
plasma	O
corticosterone	O
levels	O
were	O
decreased	O
at	O
2	O
months	O
postinjury	O
and	O
there	O
was	O
a	O
blunted	O
corticosterone	B:C0010124
increase	O
in	O
response	O
to	O
restraint	O
induced	I:C0449430
stress	I:C0449430
.	O

Resting	O
plasma	O
corticosterone	O
levels	O
were	O
decreased	O
at	O
2	O
months	O
postinjury	O
and	O
there	O
was	O
a	O
blunted	O
corticosterone	O
increase	O
in	O
response	O
to	O
restraint	B:C0449430
induced	I:C0449430
stress	I:C0449430
.	O

No	B:C0442739
changes	I:C0442739
in	O
testosterone	O
were	O
measured	O
.	O

No	O
changes	I:C0442739
in	O
testosterone	B:C0039601
were	O
measured	O
.	O

These	O
changes	O
in	O
corticosterone	B:C0010124
were	O
observed	O
concomitantly	O
with	O
altered	O
complexity	O
of	O
neuron	O
processes	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
over	O
time	O
,	O
devoid	O
of	O
neuropathology	O
or	O
astrocytosis	O
.	O

These	O
changes	O
in	O
corticosterone	O
were	O
observed	O
concomitantly	O
with	O
altered	O
complexity	O
of	O
neuron	B:C0027882
processes	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
over	O
time	O
,	O
devoid	O
of	O
neuropathology	O
or	O
astrocytosis	O
.	O

These	O
changes	O
in	O
corticosterone	O
were	O
observed	O
concomitantly	O
with	O
altered	O
complexity	O
of	O
neuron	O
processes	B:C0007613
in	O
the	O
paraventricular	O
nucleus	I:C0030532
over	O
time	O
,	O
devoid	O
of	O
neuropathology	O
or	O
astrocytosis	O
.	O

These	O
changes	O
in	O
corticosterone	O
were	O
observed	O
concomitantly	O
with	O
altered	O
complexity	O
of	O
neuron	O
processes	O
in	O
the	O
paraventricular	B:C0030532
nucleus	I:C0030532
over	O
time	O
,	O
devoid	O
of	O
neuropathology	O
or	O
astrocytosis	O
.	O

These	O
changes	O
in	O
corticosterone	O
were	O
observed	O
concomitantly	O
with	O
altered	O
complexity	O
of	O
neuron	O
processes	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
over	O
time	O
,	O
devoid	O
of	O
neuropathology	B:C1540677
or	O
astrocytosis	O
.	O

These	O
changes	O
in	O
corticosterone	O
were	O
observed	O
concomitantly	O
with	O
altered	O
complexity	O
of	O
neuron	O
processes	O
in	O
the	O
paraventricular	O
nucleus	I:C0030532
over	O
time	O
,	O
devoid	O
of	O
neuropathology	O
or	O
astrocytosis	B:C3887640
.	O

Results	O
provide	O
evidence	O
that	O
a	O
single	O
moderate	O
diffuse	B:C2832047
TBI	I:C2832047
leads	O
to	O
changes	O
in	O
corticosterone	O
function	O
,	O
which	O
can	O
contribute	O
to	O
the	O
persistence	O
of	O
symptoms	O
related	O
to	O
endocrine	O
dysfunction	O
.	O

Results	O
provide	O
evidence	O
that	O
a	O
single	O
moderate	O
diffuse	O
TBI	I:C2832047
leads	O
to	O
changes	O
in	O
corticosterone	B:C0010124
function	O
,	O
which	O
can	O
contribute	O
to	O
the	O
persistence	O
of	O
symptoms	O
related	O
to	O
endocrine	O
dysfunction	O
.	O

Future	O
experiments	B:C0681814
aim	O
to	O
evaluate	O
additional	O
HP	O
-	I:C0019932
related	I:C0019932
hormones	I:C0019932
and	O
endocrine	O
circuit	O
pathology	O
following	O
diffuse	O
TBI	I:C2832047
.	O

Future	O
experiments	O
aim	O
to	O
evaluate	O
additional	O
HP	B:C0019932
-	I:C0019932
related	I:C0019932
hormones	I:C0019932
and	O
endocrine	O
circuit	O
pathology	O
following	O
diffuse	O
TBI	I:C2832047
.	O

Future	O
experiments	O
aim	O
to	O
evaluate	O
additional	O
HP	O
-	I:C0019932
related	I:C0019932
hormones	I:C0019932
and	O
endocrine	B:C0014136
circuit	O
pathology	O
following	O
diffuse	O
TBI	I:C2832047
.	O

Future	O
experiments	O
aim	O
to	O
evaluate	O
additional	O
HP	O
-	I:C0019932
related	I:C0019932
hormones	I:C0019932
and	O
endocrine	O
circuit	O
pathology	O
following	O
diffuse	B:C2832047
TBI	I:C2832047
.	O

